The interactions with real documentation
Blood thinners: CBD can raise warfarin levels — documented INR increases requiring dose adjustment. If you take warfarin, cannabis use needs your prescriber's knowledge and likely closer INR monitoring. Seizure medications: Epidiolex labeling documents interactions with clobazam (raising its active metabolite substantially) and valproate (liver enzyme elevations) — directly relevant to epilepsy patients combining dispensary CBD with prescriptions. Sedatives, sleep medications, opioids, and alcohol: additive central-nervous-system depression — drowsiness, impaired coordination, respiratory caution at the extreme. This is the most common real-world interaction, and it's dose-dependent.
Antidepressants and psychiatric medications: evidence is thinner but caution is standard — THC can oppose treatment goals in anxiety disorders at higher doses, and CBD's enzyme inhibition can elevate levels of several SSRIs and tricyclics. Immunosuppressants (transplant patients, autoimmune disease): documented case reports of altered tacrolimus levels — coordinate with your specialist, full stop.
How to handle it like a functioning adult
Bring your full medication list to the certification appointment — that's half the visit's value. Tell every prescriber you use cannabis; clinicians adjust around it routinely and judgment-free in 2026, but only if they know. Time separation helps for some interactions but doesn't eliminate enzyme effects, which persist for days with regular CBD use.
Watch for warning signs after starting or increasing cannabis alongside other medications: unusual bruising or bleeding (warfarin), excessive sedation (CNS depressants), or any change in seizure pattern. Each warrants a call, not a wait-and-see.
The information on this site is for educational purposes only and is not medical or legal advice. Cannabis use carries risks; consult a licensed physician about whether medical cannabis is appropriate for you. Federal status (as of June 2026): marijuana dispensed under state medical licenses and FDA-approved cannabis products are Schedule III controlled substances; all other marijuana remains Schedule I under U.S. federal law. Laws cited here change; confirm current rules with the linked primary sources before acting on them.